Sagar Lonial, MD, obtained his medical degree from the University of Louisville School of Medicine, Louisville, KY, and completed an internal medicine residency at Baylor College of Medicine in Houston, TX. Prof. Lonial also completed a fellowship in hematology/oncology at Emory University School of Medicine in Atlanta, GA.
Prof. Lonial is currently Professor and Chief Medical Officer at the Winship Cancer Institute of Emory University, as well as Professor and Chair of the Department of Hematology and Medical Oncology at the Emory University School of Medicine. Prof. Lonial is an active member of the American Society of Clinical Oncology and the American Society of Hematology. He has recently received a Lifetime Achievement Award for Outstanding Contributions to Hematology-Oncology from the Indo-American Cancer Association.
Speaking on novel agents for multiple myeloma treatment
Prof. Lonial’s research focuses on multiple myeloma treatment, particularly combinations of novel agents as therapy. His most recent work is centred on drug combinations which may cause synergistic inhibition of the PI3-K/Akt pathway.